OSTEOPORE LIMITED - Announcements

Market Cap $3.512M Add to my watchlist

Healthcare Medical Instruments & Supplies

Osteopore Limited is an Australia-based medical technology company. The Company is... Osteopore Limited is an Australia-based medical technology company. The Company is engaged in commercializing a range of bespoke products specifically engineered to facilitate bone healing across multiple therapeutic areas. The Company’s patented technology fabricates specific micro-structured scaffolds for bone regeneration through three-dimensional (3D) printing and bioresorbable material. The Company’s Osteoplug in plug and strip configuration fills craniotomy gaps effortlessly. It also promotes bone tissue integration, from the skull to the bone flap. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. It also offers craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, minimally invasive skull base surgery, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, immediate implant loading, and more.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

OSX	Response to ASX Price and Volume Query	PRICE SENSITIVE	23/04/24	888.9KB	Share
OSX	Trading Halt	PRICE SENSITIVE	23/04/24	770.63KB	Share
OSX	Pause in Trading	PRICE SENSITIVE	23/04/24	116.23KB	Share
OSX	First-in-human clinical trials begin in Singapore		23/04/24	336.74KB	Share
OSX	Reinstatement to Official Quotation	PRICE SENSITIVE	16/04/24	413.16KB	Share
OSX	Appendix 4G and Corporate Governance Statement		16/04/24	466.22KB	Share
OSX	Annual Report to Shareholders		16/04/24	1.07MB	Share
OSX	Response to ASX Query Letter	PRICE SENSITIVE	15/04/24	997.19KB	Share
OSX	Osteopore extends Bridging Loan maturity date	PRICE SENSITIVE	10/04/24	469.06KB	Share
OSX	Annual General Meeting Date		08/04/24	321.23KB	Share
OSX	Ceasing to be a substantial holder		05/04/24	162.59KB	Share
OSX	Update - Proposed issue of securities - OSX		05/04/24	764.83KB	Share
OSX	Osteopore announces 97% take-up for Entitlement Offer		05/04/24	325.38KB	Share
OSX	Update - Proposed issue of securities - OSX		04/04/24	765.12KB	Share
OSX	Replacement Prospectus for Renounceable Rights Issue	PRICE SENSITIVE	04/04/24	886.15KB	Share
OSX	Update to Replacement Prospectus for Entitlement Offer	PRICE SENSITIVE	03/04/24	351.09KB	Share
OSX	Update - Proposed issue of securities - OSX		02/04/24	764.42KB	Share
OSX	OSX issues Replacement Prospectus for Entitlement Offer		02/04/24	797.67KB	Share
OSX	Letter to Eligible Shareholders		02/04/24	375.44KB	Share
OSX	Replacement Prospectus for Renounceable Rights Issue	PRICE SENSITIVE	02/04/24	987.92KB	Share
OSX	Suspension from Quotation	PRICE SENSITIVE	02/04/24	91.71KB	Share
OSX	Suspension from Quotation	PRICE SENSITIVE	28/03/24	700.87KB	Share
OSX	Amendment - OSX Singapore and Vietnam market approvals		27/03/24	349.08KB	Share
OSX	Osteopore secures Singapore and Vietnam market approvals	PRICE SENSITIVE	27/03/24	344.23KB	Share
OSX	Osteopore progresses Australian bone scaffold trials		26/03/24	343.36KB	Share
OSX	Letter to Ineligible Shareholders		19/03/24	139.57KB	Share
OSX	Letter to Eligible Shareholders		19/03/24	182.27KB	Share
OSX	Prospectus despatched		19/03/24	353.4KB	Share
OSX	Update - Proposed issue of securities - OSX		13/03/24	763.2KB	Share
OSX	Proposed issue of securities - OSX		13/03/24	25.17KB	Share
OSX	Prospectus for Renounceable Rights Issue	PRICE SENSITIVE	13/03/24	861.28KB	Share
OSX	OSX Entitlement Offer to support growth	PRICE SENSITIVE	13/03/24	369.97KB	Share
OSX	Appendix 3Y - Change of Director's Interest Notice x 3		06/03/24	235.59KB	Share
OSX	Update - Consolidation/Split - OSX		04/03/24	16.95KB	Share
OSX	Completion of Consolidation of Capital		04/03/24	346.33KB	Share
OSX	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	29/02/24	295.7KB	Share
OSX	OSX advances capital consolidation for long-term growth		21/02/24	404.06KB	Share
OSX	Activities Update Qtr Ending December 2023 and Appendix 4C	PRICE SENSITIVE	31/01/24	3.24MB	Share
OSX	OSX achieves 100k implants, to accelerate commercialisation		29/01/24	371.96KB	Share
OSX	Consolidation/Split - OSX		23/01/24	26.3KB	Share
OSX	Notice of General Meeting	PRICE SENSITIVE	23/01/24	2.21MB	Share
OSX	Osteopore signs Bridging Loan agreement	PRICE SENSITIVE	28/12/23	371.4KB	Share
OSX	Osteopore secures Hainan Approval for Neurosurgery		18/12/23	442.23KB	Share
OSX	Change of Director's Interest Notice - TSH		05/12/23	189.08KB	Share
OSX	Negotiation ongoing for InnoVentures Definitive JV Agreement		30/11/23	342.5KB	Share
OSX	Activities Update Qtr Ending September 2023 and Appendix 4C	PRICE SENSITIVE	31/10/23	3.5MB	Share
OSX	Change of Director's Interest Notice		05/10/23	493.47KB	Share
OSX	Clarification Announcement		18/09/23	348.85KB	Share
OSX	Investor Webinar Presentation		18/09/23	344.37KB	Share
OSX	MOU with Temasek-linked Innoventures - Orthopaedics in China	PRICE SENSITIVE	12/09/23	384.17KB	Share
OSX	Resignation of Joint Company Secretary		04/09/23	333.14KB	Share
OSX	Half Yearly Report and Accounts	PRICE SENSITIVE	31/08/23	613.27KB	Share
OSX	Timeline extended for definitive agreements with CellHeal		29/08/23	368.44KB	Share
OSX	Notification of cessation of securities - OSX		28/08/23	21.54KB	Share
OSX	Clarification Announcement		01/08/23	300.43KB	Share
OSX	Investor Presentation		01/08/23	7.57MB	Share
OSX	Initial Director's Interest Notice - MK		31/07/23	396.67KB	Share
OSX	Activities Update Qtr Ending June 2023 and Appendix 4C	PRICE SENSITIVE	31/07/23	4.12MB	Share
OSX	OSX receives A$10m commitment for commercialisation in China	PRICE SENSITIVE	25/07/23	389.6KB	Share
OSX	Osteopore strengthens Board & Management by key appointments	PRICE SENSITIVE	18/07/23	397.82KB	Share
OSX	Change of Director's Interest Notice - ML		07/07/23	191.42KB	Share
OSX	Rectification of Breach of ASX Listing Rule 10.11		07/07/23	274.79KB	Share
OSX	Application for quotation of securities - OSX		29/06/23	29.12KB	Share
OSX	Notice of Breach of ASX Listing Rule 10.11		26/06/23	260.8KB	Share
OSX	Change of Share Registry Details		23/06/23	229.44KB	Share
OSX	Shortfall oversubscribed for Osteopore's Global Expansion		20/06/23	303.61KB	Share
OSX	Strategic Partnership for Clinical R&D in China worth $4M	PRICE SENSITIVE	08/06/23	269.56KB	Share
OSX	Results of Annual General Meeting		30/05/23	267.26KB	Share
OSX	Notification regarding unquoted securities - OSX		25/05/23	27.7KB	Share
OSX	Largest South African Medical Insurer provides cover for OSX	PRICE SENSITIVE	16/05/23	278.1KB	Share
OSX	Notification regarding unquoted securities - OSX		12/05/23	28.58KB	Share
OSX	Change of Registered Office		05/05/23	140.94KB	Share
OSX	Change of Director's Interest Notice - TSH		28/04/23	226.02KB	Share
OSX	Change of Director's Interest Notice - ML		28/04/23	224.21KB	Share
OSX	Notice of Annual General Meeting		28/04/23	615.69KB	Share
OSX	Activities Update Qtr Ending March 2023 and Appendix 4C	PRICE SENSITIVE	28/04/23	3.43MB	Share
OSX	OSX Successfully transitions to EU Medical Device Regulation	PRICE SENSITIVE	27/04/23	238.93KB	Share
OSX	Reinstatement of Security Class to Quotation	PRICE SENSITIVE	26/04/23	412.9KB	Share
OSX	Top 20 and Distribution List - Options		26/04/23	17.33KB	Share
OSX	Application for quotation of securities - OSX		24/04/23	25.08KB	Share
OSX	Application for quotation of securities - OSX		24/04/23	29.48KB	Share
OSX	Security Class Suspension from Quotation	PRICE SENSITIVE	24/04/23	416.22KB	Share
OSX	Non-Renounceable Entitlement Offer - Results	PRICE SENSITIVE	24/04/23	233.65KB	Share
OSX	Osteopore Increases Presence in Singapore Dental Market		14/04/23	247.63KB	Share
OSX	Osteopore to Commercialise Innovative Bone Rengeneration Tec		14/04/23	264.89KB	Share
OSX	Employee Securities Incentive Plan		13/04/23	370.57KB	Share
OSX	Non-Renounceable Entitlement Offer - Closing Date		13/04/23	261.56KB	Share
OSX	OSX Strengthens Presence in the Eastern Region of the USA	PRICE SENSITIVE	11/04/23	237.94KB	Share
OSX	Annual General Meeting Date		05/04/23	270.93KB	Share
OSX	Results of General Meeting		31/03/23	238.21KB	Share
OSX	Appendix 4G and Corporate Governance Statement		31/03/23	466.34KB	Share
OSX	Annual Report to Shareholders		31/03/23	950.12KB	Share
OSX	OSX Completes Acquisition to Accelerate Revenue Growth	PRICE SENSITIVE	31/03/23	235.22KB	Share
OSX	Update - Proposed issue of securities - OSX		30/03/23	770.8KB	Share
OSX	Non-Renounceable Entitlement Offer Extension		30/03/23	154.69KB	Share
OSX	OSX Product Approved for Additional Applications in Taiwan		27/03/23	196.75KB	Share
OSX	Prospectus despatched		21/03/23	145.2KB	Share
OSX	Update - Proposed issue of securities - OSX		14/03/23	42.36KB	Share
OSX	Letter to Optionholders		13/03/23	152.5KB	Share
OSX	Letter to Ineligible Shareholders		13/03/23	151.86KB	Share

OSX Response to ASX Price and Volume Query
23/04/24	PRICE SENSITIVE	888.9KB	Share
OSX Trading Halt
23/04/24	PRICE SENSITIVE	770.63KB	Share
OSX Pause in Trading
23/04/24	PRICE SENSITIVE	116.23KB	Share
OSX First-in-human clinical trials begin in Singapore
23/04/24		336.74KB	Share
OSX Reinstatement to Official Quotation
16/04/24	PRICE SENSITIVE	413.16KB	Share
OSX Appendix 4G and Corporate Governance Statement
16/04/24		466.22KB	Share
OSX Annual Report to Shareholders
16/04/24		1.07MB	Share
OSX Response to ASX Query Letter
15/04/24	PRICE SENSITIVE	997.19KB	Share
OSX Osteopore extends Bridging Loan maturity date
10/04/24	PRICE SENSITIVE	469.06KB	Share
OSX Annual General Meeting Date
08/04/24		321.23KB	Share
OSX Ceasing to be a substantial holder
05/04/24		162.59KB	Share
OSX Update - Proposed issue of securities - OSX
05/04/24		764.83KB	Share
OSX Osteopore announces 97% take-up for Entitlement Offer
05/04/24		325.38KB	Share
OSX Update - Proposed issue of securities - OSX
04/04/24		765.12KB	Share
OSX Replacement Prospectus for Renounceable Rights Issue
04/04/24	PRICE SENSITIVE	886.15KB	Share
OSX Update to Replacement Prospectus for Entitlement Offer
03/04/24	PRICE SENSITIVE	351.09KB	Share
OSX Update - Proposed issue of securities - OSX
02/04/24		764.42KB	Share
OSX OSX issues Replacement Prospectus for Entitlement Offer
02/04/24		797.67KB	Share
OSX Letter to Eligible Shareholders
02/04/24		375.44KB	Share
OSX Replacement Prospectus for Renounceable Rights Issue
02/04/24	PRICE SENSITIVE	987.92KB	Share
OSX Suspension from Quotation
02/04/24	PRICE SENSITIVE	91.71KB	Share
OSX Suspension from Quotation
28/03/24	PRICE SENSITIVE	700.87KB	Share
OSX Amendment - OSX Singapore and Vietnam market approvals
27/03/24		349.08KB	Share
OSX Osteopore secures Singapore and Vietnam market approvals
27/03/24	PRICE SENSITIVE	344.23KB	Share
OSX Osteopore progresses Australian bone scaffold trials
26/03/24		343.36KB	Share
OSX Letter to Ineligible Shareholders
19/03/24		139.57KB	Share
OSX Letter to Eligible Shareholders
19/03/24		182.27KB	Share
OSX Prospectus despatched
19/03/24		353.4KB	Share
OSX Update - Proposed issue of securities - OSX
13/03/24		763.2KB	Share
OSX Proposed issue of securities - OSX
13/03/24		25.17KB	Share
OSX Prospectus for Renounceable Rights Issue
13/03/24	PRICE SENSITIVE	861.28KB	Share
OSX OSX Entitlement Offer to support growth
13/03/24	PRICE SENSITIVE	369.97KB	Share
OSX Appendix 3Y - Change of Director's Interest Notice x 3
06/03/24		235.59KB	Share
OSX Update - Consolidation/Split - OSX
04/03/24		16.95KB	Share
OSX Completion of Consolidation of Capital
04/03/24		346.33KB	Share
OSX Appendix 4E Preliminary Final Report
29/02/24	PRICE SENSITIVE	295.7KB	Share
OSX OSX advances capital consolidation for long-term growth
21/02/24		404.06KB	Share
OSX Activities Update Qtr Ending December 2023 and Appendix 4C
31/01/24	PRICE SENSITIVE	3.24MB	Share
OSX OSX achieves 100k implants, to accelerate commercialisation
29/01/24		371.96KB	Share
OSX Consolidation/Split - OSX
23/01/24		26.3KB	Share
OSX Notice of General Meeting
23/01/24	PRICE SENSITIVE	2.21MB	Share
OSX Osteopore signs Bridging Loan agreement
28/12/23	PRICE SENSITIVE	371.4KB	Share
OSX Osteopore secures Hainan Approval for Neurosurgery
18/12/23		442.23KB	Share
OSX Change of Director's Interest Notice - TSH
05/12/23		189.08KB	Share
OSX Negotiation ongoing for InnoVentures Definitive JV Agreement
30/11/23		342.5KB	Share
OSX Activities Update Qtr Ending September 2023 and Appendix 4C
31/10/23	PRICE SENSITIVE	3.5MB	Share
OSX Change of Director's Interest Notice
05/10/23		493.47KB	Share
OSX Clarification Announcement
18/09/23		348.85KB	Share
OSX Investor Webinar Presentation
18/09/23		344.37KB	Share
OSX MOU with Temasek-linked Innoventures - Orthopaedics in China
12/09/23	PRICE SENSITIVE	384.17KB	Share
OSX Resignation of Joint Company Secretary
04/09/23		333.14KB	Share
OSX Half Yearly Report and Accounts
31/08/23	PRICE SENSITIVE	613.27KB	Share
OSX Timeline extended for definitive agreements with CellHeal
29/08/23		368.44KB	Share
OSX Notification of cessation of securities - OSX
28/08/23		21.54KB	Share
OSX Clarification Announcement
01/08/23		300.43KB	Share
OSX Investor Presentation
01/08/23		7.57MB	Share
OSX Initial Director's Interest Notice - MK
31/07/23		396.67KB	Share
OSX Activities Update Qtr Ending June 2023 and Appendix 4C
31/07/23	PRICE SENSITIVE	4.12MB	Share
OSX OSX receives A$10m commitment for commercialisation in China
25/07/23	PRICE SENSITIVE	389.6KB	Share
OSX Osteopore strengthens Board & Management by key appointments
18/07/23	PRICE SENSITIVE	397.82KB	Share
OSX Change of Director's Interest Notice - ML
07/07/23		191.42KB	Share
OSX Rectification of Breach of ASX Listing Rule 10.11
07/07/23		274.79KB	Share
OSX Application for quotation of securities - OSX
29/06/23		29.12KB	Share
OSX Notice of Breach of ASX Listing Rule 10.11
26/06/23		260.8KB	Share
OSX Change of Share Registry Details
23/06/23		229.44KB	Share
OSX Shortfall oversubscribed for Osteopore's Global Expansion
20/06/23		303.61KB	Share
OSX Strategic Partnership for Clinical R&D in China worth $4M
08/06/23	PRICE SENSITIVE	269.56KB	Share
OSX Results of Annual General Meeting
30/05/23		267.26KB	Share
OSX Notification regarding unquoted securities - OSX
25/05/23		27.7KB	Share
OSX Largest South African Medical Insurer provides cover for OSX
16/05/23	PRICE SENSITIVE	278.1KB	Share
OSX Notification regarding unquoted securities - OSX
12/05/23		28.58KB	Share
OSX Change of Registered Office
05/05/23		140.94KB	Share
OSX Change of Director's Interest Notice - TSH
28/04/23		226.02KB	Share
OSX Change of Director's Interest Notice - ML
28/04/23		224.21KB	Share
OSX Notice of Annual General Meeting
28/04/23		615.69KB	Share
OSX Activities Update Qtr Ending March 2023 and Appendix 4C
28/04/23	PRICE SENSITIVE	3.43MB	Share
OSX OSX Successfully transitions to EU Medical Device Regulation
27/04/23	PRICE SENSITIVE	238.93KB	Share
OSX Reinstatement of Security Class to Quotation
26/04/23	PRICE SENSITIVE	412.9KB	Share
OSX Top 20 and Distribution List - Options
26/04/23		17.33KB	Share
OSX Application for quotation of securities - OSX
24/04/23		25.08KB	Share
OSX Application for quotation of securities - OSX
24/04/23		29.48KB	Share
OSX Security Class Suspension from Quotation
24/04/23	PRICE SENSITIVE	416.22KB	Share
OSX Non-Renounceable Entitlement Offer - Results
24/04/23	PRICE SENSITIVE	233.65KB	Share
OSX Osteopore Increases Presence in Singapore Dental Market
14/04/23		247.63KB	Share
OSX Osteopore to Commercialise Innovative Bone Rengeneration Tec
14/04/23		264.89KB	Share
OSX Employee Securities Incentive Plan
13/04/23		370.57KB	Share
OSX Non-Renounceable Entitlement Offer - Closing Date
13/04/23		261.56KB	Share
OSX OSX Strengthens Presence in the Eastern Region of the USA
11/04/23	PRICE SENSITIVE	237.94KB	Share
OSX Annual General Meeting Date
05/04/23		270.93KB	Share
OSX Results of General Meeting
31/03/23		238.21KB	Share
OSX Appendix 4G and Corporate Governance Statement
31/03/23		466.34KB	Share
OSX Annual Report to Shareholders
31/03/23		950.12KB	Share
OSX OSX Completes Acquisition to Accelerate Revenue Growth
31/03/23	PRICE SENSITIVE	235.22KB	Share
OSX Update - Proposed issue of securities - OSX
30/03/23		770.8KB	Share
OSX Non-Renounceable Entitlement Offer Extension
30/03/23		154.69KB	Share
OSX OSX Product Approved for Additional Applications in Taiwan
27/03/23		196.75KB	Share
OSX Prospectus despatched
21/03/23		145.2KB	Share
OSX Update - Proposed issue of securities - OSX
14/03/23		42.36KB	Share
OSX Letter to Optionholders
13/03/23		152.5KB	Share
OSX Letter to Ineligible Shareholders
13/03/23		151.86KB	Share

REFRESH

1 2

(20min delay)
Last 34.0¢		Change -0.055(13.9%)		Mkt cap ! $3.512M

Open	High	Low	Value	Volume
35.0¢	40.5¢	31.5¢	$184.3K	515.5K

Buyers (Bids)

No.	Vol.	Price($)
1	2000	33.0¢

Sellers (Offers)

Price($)	Vol.	No.
34.0¢	10005	1

View Market Depth

No.	Vol.	Price($)
1	2000	0.330
1	10000	0.325
2	5300	0.315
1	6000	0.310
3	39700	0.300

Price($)	Vol.	No.
0.340	10005	1
0.350	1229	1
0.390	4667	1
0.395	8155	1
0.400	7142	2

Last trade - 16.10pm 25/04/2024 (20 minute delay)

OSX (ASX) Chart

OSTEOPORE LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available